Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q43047140 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241121000317.0 | ||
| 008 | 241121nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q43047140 | ||
| 024 | ‡a 0000-0002-7097-9651 ‡2 orcid | ||
| 024 | ‡a 55970891300 ‡2 scopus | ||
| 035 | ‡a (OCoLC)Q43047140 | ||
| 100 | 0 | ‡a Manuel Rodríguez-Iglesias ‡9 ast ‡9 es ‡9 sl | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a Manuel Rodríguez-Iglesias ‡c researcher ‡9 en | |
| 400 | 0 | ‡a Manuel Rodríguez-Iglesias ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's A 3-year follow-up of HCV-RNA viraemia in haemodialysis patients. | ||
| 670 | ‡a Author's Annual fluctuation in the rate of resistant bacteria isolated as an indicator in the control of hospital-acquired infections. | ||
| 670 | ‡a Author's Candida galli as a cause of tinea unguium-molecular characterization of a rare clinical fungal entity | ||
| 670 | ‡a Author's Caracterización de blaOXA-48 detectada en cepas clínicas de Enterobacter cloacae aisladas en el sur de España | ||
| 670 | ‡a Author's Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods | ||
| 670 | ‡a Author's Diagnóstico molecular del papilomavirus humano: nuevos desafíos en un escenario diferente | ||
| 670 | ‡a Author's Diversity of bla genes and low incidence of CTX-M in plasmid-mediated AmpC-producing Escherichia coli clinical isolates | ||
| 670 | ‡a Author's ELISA test for the detection of Entamoeba histolytica in stool specimens | ||
| 670 | ‡a Author's Fungemia due to Trichosporon asahii in a patient with hematological malignancy | ||
| 670 | ‡a Author's Haemolytic uraemic syndrome associated with bloody diarrhoea caused by Streptococcus dysgalactiae | ||
| 670 | ‡a Author's Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis. | ||
| 670 | ‡a Author's [HIV-2 and HTLV-I/II infections in Spain]. | ||
| 670 | ‡a Author's Hospital-based surveillance for HTLV-1/2 infections in Spain. | ||
| 670 | ‡a Author's Identificación de Mycobacterium tuberculosis por inmunocromatografía a partir de cultivos sólidos | ||
| 670 | ‡a Author's Improved detection of HIV p24 antigen in serum after acid pretreatment | ||
| 670 | ‡a Author's Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain | ||
| 670 | ‡a Author's Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain | ||
| 670 | ‡a Author's Otomycosis due to filamentous fungi | ||
| 670 | ‡a Author's Performance of the New INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens. | ||
| 670 | ‡a Author's Pneumonia in HIV-infected patients in the HAART era: Incidence, risk, and impact of the pneumococcal vaccination | ||
| 670 | ‡a Author's Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey | ||
| 670 | ‡a Author's Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain | ||
| 670 | ‡a Author's Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain | ||
| 670 | ‡a Author's Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain | ||
| 670 | ‡a Author's Up-regulation of FOXP3 and induction of suppressive function in CD4+ Jurkat T-cells expressing hepatitis C virus core protein | ||
| 670 | ‡a Author's Urethritis due to Corynebacterium glucuronolyticum | ||
| 670 | ‡a Author's Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results | ||
| 670 | ‡a Author's Viral infections of the central nervous system in Spain: A prospective study | ||
| 909 | ‡a (orcid) 0000000270979651 ‡9 1 | ||
| 909 | ‡a (scopus) 55970891300 ‡9 1 | ||
| 919 | ‡a urethritisduetocorynebacteriumglucuronolyticum ‡A Urethritis due to Corynebacterium glucuronolyticum ‡9 1 | ||
| 919 | ‡a candidagalliasacauseoftineaunguiummolecularcharacterizationofarareclinicalfungalentity ‡A Candida galli as a cause of tinea unguium-molecular characterization of a rare clinical fungal entity ‡9 1 | ||
| 919 | ‡a pneumoniainhivinfectedpatientsinthehaarteraincidenceriskandimpactofthepneumococcalvaccination ‡A Pneumonia in HIV-infected patients in the HAART era: Incidence, risk, and impact of the pneumococcal vaccination ‡9 1 | ||
| 919 | ‡a useofcervistahpvhrassayfordetectionofhumanpapillomavirusinsampleswithhybridcaptureborderlinenegativeresults ‡A Use of Cervista HPV HR assay for detection of human papillomavirus in samples with hybrid capture borderline negative results ‡9 1 | ||
| 919 | ‡a prevalenceofhtlv12infectionsinspainacrosssectionalhospitalbasedsurvey ‡A Prevalence of HTLV-1/2 Infections in Spain: A Cross-Sectional Hospital-Based Survey ‡9 1 | ||
| 919 | ‡a caracterizaciondeblaoxa48detectadaencepasclinicasdeenterobactercloacaeaisladasenelsurdeespana ‡A Caracterización de blaOXA-48 detectada en cepas clínicas de Enterobacter cloacae aisladas en el sur de España ‡9 1 | ||
| 919 | ‡a seroprevalenceofhepatitisavirusantibodiesinapediatricpopulationofsouthernspain ‡A Seroprevalence of hepatitis A virus antibodies in a pediatric population of southern Spain ‡9 1 | ||
| 919 | ‡a viralinfectionsofthecentralnervoussysteminspainaprospectivestudy ‡A Viral infections of the central nervous system in Spain: A prospective study ‡9 1 | ||
| 919 | ‡a comparisonofhumanpapillomavirusgenotypingusingcommercialassaysbasedonpcrandreversehybridizationmethods ‡A Comparison of human papillomavirus genotyping using commercial assays based on PCR and reverse hybridization methods ‡9 1 | ||
| 919 | ‡a seroprevalenceofhtlv12infectionamongnativeandimmigrantpregnantwomeninspain ‡A Seroprevalence of HTLV-1/2 infection among native and immigrant pregnant women in Spain ‡9 1 | ||
| 919 | ‡a hospitalbasedsurveillanceforhtlv12infectionsinspain ‡A Hospital-based surveillance for HTLV-1/2 infections in Spain. ‡9 1 | ||
| 919 | ‡a hiv2andhtlv12infectionsinspain ‡A [HIV-2 and HTLV-I/II infections in Spain]. ‡9 1 | ||
| 919 | ‡a identificaciondemycobacteriumtuberculosisporinmunocromatografiaapartirdecultivossolidos ‡A Identificación de Mycobacterium tuberculosis por inmunocromatografía a partir de cultivos sólidos ‡9 1 | ||
| 919 | ‡a trendsintheprevalenceanddistributionofhtlv1andhtlv2infectionsinspain ‡A Trends in the prevalence and distribution of HTLV-1 and HTLV-2 infections in Spain ‡9 1 | ||
| 919 | ‡a diagnosticomoleculardelpapilomavirushumanonuevosdesafiosen1escenariodiferente ‡A Diagnóstico molecular del papilomavirus humano: nuevos desafíos en un escenario diferente ‡9 1 | ||
| 919 | ‡a performanceofthenewinnolipahpvextratogenotypehumanpapillomavirusincervicalcellspecimens ‡A Performance of the New INNO-LiPA HPV extra to genotype human papillomavirus in cervical cell specimens. ‡9 1 | ||
| 919 | ‡a improveddetectionofhivp24antigeninserumafteracidpretreatment ‡A Improved detection of HIV p24 antigen in serum after acid pretreatment ‡9 1 | ||
| 919 | ‡a hepatitis100viruscoreproteinupregulatesanergyrelatedgenesandanewsetofgeneswhichaffectstcellhomeostasis ‡A Hepatitis C virus core protein up-regulates anergy-related genes and a new set of genes, which affects T cell homeostasis. ‡9 1 | ||
| 919 | ‡a haemolyticuraemicsyndromeassociatedwithbloodydiarrhoeacausedbystreptococcusdysgalactiae ‡A Haemolytic uraemic syndrome associated with bloody diarrhoea caused by Streptococcus dysgalactiae ‡9 1 | ||
| 919 | ‡a fungemiaduetotrichosporonasahiiinapatientwithhematologicalmalignancy ‡A Fungemia due to Trichosporon asahii in a patient with hematological malignancy ‡9 1 | ||
| 919 | ‡a elisatestforthedetectionofentamoebahistolyticainstoolspecimens ‡A ELISA test for the detection of Entamoeba histolytica in stool specimens ‡9 1 | ||
| 919 | ‡a diversityofblagenesandlowincidenceofctx1000inplasmidmediatedampcproducingescherichiacoliclinicalisolates ‡A Diversity of bla genes and low incidence of CTX-M in plasmid-mediated AmpC-producing Escherichia coli clinical isolates ‡9 1 | ||
| 919 | ‡a 3yearfollowupofhcvrnaviraemiainhaemodialysispatients ‡A A 3-year follow-up of HCV-RNA viraemia in haemodialysis patients. ‡9 1 | ||
| 919 | ‡a infectionwithhumantlymphotropicvirustype1inorgantransplantdonorsandrecipientsinspain ‡A Infection with human T lymphotropic virus type I in organ transplant donors and recipients in Spain ‡9 1 | ||
| 919 | ‡a upregulationoffoxp3andinductionofsuppressivefunctionincd4+jurkattcellsexpressinghepatitis100viruscoreprotein ‡A Up-regulation of FOXP3 and induction of suppressive function in CD4+ Jurkat T-cells expressing hepatitis C virus core protein ‡9 1 | ||
| 919 | ‡a molecularepidemiologyandclinicalfeaturesofhumantcelllymphotropicvirustype1infectioninspain ‡A Molecular epidemiology and clinical features of human T cell lymphotropic virus type 1 infection in Spain ‡9 1 | ||
| 919 | ‡a annualfluctuationintherateofresistantbacteriaisolatedasanindicatorinthecontrolofhospitalacquiredinfections ‡A Annual fluctuation in the rate of resistant bacteria isolated as an indicator in the control of hospital-acquired infections. ‡9 1 | ||
| 919 | ‡a otomycosisduetofilamentousfungi ‡A Otomycosis due to filamentous fungi ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 RERO|A003888780 | ||
| 996 | ‡2 BNE|XX1612243 | ||
| 996 | ‡2 J9U|987007420479305171 | ||
| 996 | ‡2 BNE|XX1112291 | ||
| 996 | ‡2 BNE|XX1463876 | ||
| 996 | ‡2 BNC|981058508190606706 | ||
| 996 | ‡2 SUDOC|20143833X | ||
| 996 | ‡2 SUDOC|158315197 | ||
| 996 | ‡2 BNC|981058522907706706 | ||
| 996 | ‡2 BNE|XX1577089 | ||
| 996 | ‡2 PTBNP|181972 | ||
| 996 | ‡2 RERO|A027166107 | ||
| 996 | ‡2 BNE|XX5223800 | ||
| 996 | ‡2 LC|no 97062335 | ||
| 996 | ‡2 BNE|XX1013823 | ||
| 996 | ‡2 LC|n 94045646 | ||
| 996 | ‡2 BNE|XX1170560 | ||
| 996 | ‡2 RERO|A013716456 | ||
| 996 | ‡2 ISNI|000000005136733X | ||
| 996 | ‡2 LC|no2006113062 | ||
| 996 | ‡2 ISNI|0000000081582794 | ||
| 996 | ‡2 BLBNB|000241857 | ||
| 996 | ‡2 BNE|XX1076081 | ||
| 996 | ‡2 BNE|XX852196 | ||
| 996 | ‡2 BNE|XX4807578 | ||
| 996 | ‡2 ISNI|0000000067994557 | ||
| 996 | ‡2 BNE|XX1006428 | ||
| 996 | ‡2 DNB|1056311592 | ||
| 996 | ‡2 BNE|XX1699587 | ||
| 996 | ‡2 BNE|XX1133499 | ||
| 996 | ‡2 ISNI|0000000059629365 | ||
| 996 | ‡2 DNB|141452900 | ||
| 996 | ‡2 ISNI|0000000021127239 | ||
| 996 | ‡2 BNE|XX929566 | ||
| 996 | ‡2 DNB|105658274X | ||
| 996 | ‡2 LC|n 2014191560 | ||
| 996 | ‡2 LC|n 91081654 | ||
| 996 | ‡2 LC|n 78089516 | ||
| 996 | ‡2 BNE|XX1014978 | ||
| 996 | ‡2 SUDOC|084533773 | ||
| 996 | ‡2 BNC|981058528100406706 | ||
| 996 | ‡2 BNCHL|10000000000000000142407 | ||
| 996 | ‡2 ISNI|0000000107792264 | ||
| 996 | ‡2 BNF|14637101 | ||
| 996 | ‡2 ISNI|0000000030648140 | ||
| 996 | ‡2 LC|n 85315201 | ||
| 996 | ‡2 BNF|17119542 | ||
| 996 | ‡2 JPG|500037453 | ||
| 996 | ‡2 DNB|1141059959 | ||
| 996 | ‡2 ISNI|0000000065684758 | ||
| 996 | ‡2 LC|no2024124141 | ||
| 996 | ‡2 BNE|XX836913 | ||
| 996 | ‡2 LC|no2020127638 | ||
| 996 | ‡2 BNE|XX887870 | ||
| 996 | ‡2 BNE|XX1116766 | ||
| 996 | ‡2 DNB|131376993 | ||
| 996 | ‡2 NLA|000035726591 | ||
| 996 | ‡2 DNB|173941702 | ||
| 996 | ‡2 NTA|078388252 | ||
| 996 | ‡2 LC|no2016066693 | ||
| 996 | ‡2 BNF|17018005 | ||
| 996 | ‡2 RERO|A025725956 | ||
| 996 | ‡2 BNE|XX920004 | ||
| 996 | ‡2 BNC|981058512474306706 | ||
| 996 | ‡2 LC|n 2003114885 | ||
| 996 | ‡2 ISNI|0000000060747385 | ||
| 996 | ‡2 BNE|XX1314972 | ||
| 996 | ‡2 ISNI|0000000115781602 | ||
| 996 | ‡2 DBC|87097968475902 | ||
| 996 | ‡2 LC|n 81011422 | ||
| 996 | ‡2 BNE|XX1689440 | ||
| 996 | ‡2 SUDOC|077755391 | ||
| 996 | ‡2 BNE|XX922529 | ||
| 996 | ‡2 ISNI|0000000383675347 | ||
| 996 | ‡2 SUDOC|114444900 | ||
| 996 | ‡2 BNE|XX1760432 | ||
| 996 | ‡2 SUDOC|087927489 | ||
| 996 | ‡2 ISNI|0000000060853022 | ||
| 996 | ‡2 ISNI|0000000021860633 | ||
| 996 | ‡2 BNE|XX4758778 | ||
| 996 | ‡2 NTA|280584962 | ||
| 996 | ‡2 JPG|500225644 | ||
| 996 | ‡2 BNE|XX5605868 | ||
| 996 | ‡2 ISNI|0000000423117615 | ||
| 996 | ‡2 ISNI|0000000060119522 | ||
| 996 | ‡2 ISNI|0000000118557980 | ||
| 996 | ‡2 CAOONL|ncf13723677 | ||
| 996 | ‡2 BNE|XX4818602 | ||
| 996 | ‡2 BNC|981058613453606706 | ||
| 996 | ‡2 BNC|981058609596006706 | ||
| 996 | ‡2 SUDOC|078021065 | ||
| 996 | ‡2 BNE|XX976136 | ||
| 996 | ‡2 DNB|130224235 | ||
| 996 | ‡2 BNE|XX970523 | ||
| 996 | ‡2 BIBSYS|6002563 | ||
| 996 | ‡2 ISNI|0000000079882915 | ||
| 996 | ‡2 BNE|XX959966 | ||
| 996 | ‡2 ISNI|0000000059322494 | ||
| 996 | ‡2 BNE|XX6173529 | ||
| 996 | ‡2 ISNI|0000000059580610 | ||
| 996 | ‡2 BNE|XX1800381 | ||
| 996 | ‡2 BNE|XX5275216 | ||
| 996 | ‡2 ISNI|0000000003055139 | ||
| 996 | ‡2 ISNI|0000000036234985 | ||
| 996 | ‡2 DNB|124419364 | ||
| 996 | ‡2 BNE|XX958983 | ||
| 996 | ‡2 SUDOC|280616295 | ||
| 996 | ‡2 LC|nr2003012401 | ||
| 996 | ‡2 BNE|XX989263 | ||
| 996 | ‡2 BNE|XX4921043 | ||
| 996 | ‡2 LC|n 00096280 | ||
| 996 | ‡2 DNB|131761994 | ||
| 996 | ‡2 SZ|1038383064 | ||
| 996 | ‡2 BIBSYS|1011151 | ||
| 996 | ‡2 ISNI|0000000048783172 | ||
| 996 | ‡2 BNE|XX4660267 | ||
| 996 | ‡2 BNF|17707647 | ||
| 996 | ‡2 BNE|XX939937 | ||
| 996 | ‡2 BNE|XX964630 | ||
| 996 | ‡2 BNE|XX996000 | ||
| 996 | ‡2 ISNI|0000000061208420 | ||
| 996 | ‡2 LC|n 88106191 | ||
| 996 | ‡2 SUDOC|085571202 | ||
| 996 | ‡2 ISNI|000000003919435X | ||
| 996 | ‡2 BNE|XX1315018 | ||
| 996 | ‡2 BNE|XX1295128 | ||
| 996 | ‡2 BNE|XX976018 | ||
| 996 | ‡2 BNE|XX1315012 | ||
| 996 | ‡2 DNB|1056605200 | ||
| 996 | ‡2 DNB|1038383064 | ||
| 996 | ‡2 BNE|XX4950780 | ||
| 996 | ‡2 DNB|1056685387 | ||
| 996 | ‡2 ISNI|0000000060912950 | ||
| 996 | ‡2 LC|n 2005067068 | ||
| 996 | ‡2 SUDOC|256841934 | ||
| 996 | ‡2 DNB|1157343260 | ||
| 996 | ‡2 NII|DA08741987 | ||
| 996 | ‡2 BIBSYS|90930643 | ||
| 996 | ‡2 ISNI|0000000115768053 | ||
| 996 | ‡2 RERO|A027475395 | ||
| 996 | ‡2 BNE|XX1158767 | ||
| 996 | ‡2 ISNI|0000000059967575 | ||
| 996 | ‡2 LC|no2018013110 | ||
| 996 | ‡2 DNB|1056706635 | ||
| 996 | ‡2 DNB|1056193816 | ||
| 996 | ‡2 BNC|981058517710706706 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
